Ana Rita Dias Araújo

Ana Rita Dias Araújo

Auto-generated profile, based on publicly available information

Ana Rita Dias Araújo

UMR 7275, Institut de Pharmacologie Moléculaire et Cellulaire, Université Côte d’Azur, CNRS and Inserm, Sophia Antipolis, Valbonne, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2024 in Journal of Cell Biology
Verified
Journal Article
Open access
AAAna Rita Dias Araújo
Ana Rita Dias Araújo
ABAbdoul Akim Bello
Abdoul Akim Bello
JBJoëlle Bigay
Joëlle Bigay
CFCéline Franckhauser
Céline Franckhauser
RGRomain Gautier
Romain Gautier
BABruno Antonny
Bruno Antonny
Perilipins (PLINs), the most abundant proteins on lipid droplets (LDs), display similar domain organization including amphipathic helices (AH). However, the five human PLINs bind different LDs, suggesting different modes of interaction. We established a minimal system whereby artificial LDs covered with defined polar lipids were transiently deformed to promote surface tension. Binding of purified PLIN3 and PLIN4 AH was strongly facilitated by tension but was poorly sensitive to phospholipid composition and to the presence of diacylglycerol. Accordingly, LD coverage by PLIN3 increased as phospholipid coverage decreased. In contrast, PLIN1 bound readily to LDs fully covered by phospholipids; PLIN2 showed an intermediate behavior between PLIN1 and PLIN3. In human adipocytes, PLIN3/4 were found in a soluble pool and relocated to LDs upon stimulation of fast triglyceride synthesis, whereas PLIN1 and PLIN2 localized to pre-existing LDs, consistent with the large difference in LD avidity observed in vitro. We conclude that the PLIN repertoire is adapted to handling LDs with different surface properties.

Verified
Journal Article
Open access
PDF file
Catarina MoraisCatarina Morais
Catarina Morais
ACAna Cardoso
Ana Cardoso
AAAna Rita D. Araújo
Ana Rita D. Araújo
Ana ReisAna Reis
Ana Reis
PDPedro Domingues
Pedro Domingues
AJAmália S Jurado
Amália S Jurado
Modulation of lipid metabolism is a well-established cancer hallmark, and SCD1 has been recognized as a key enzyme in promoting cancer cell growth, including in glioblastoma (GBM), the deadliest brain tumor and a paradigm of cancer resistance. The central goal of this work was to identify, by MS, the phospholipidome alterations resulting from the silencing of SCD1 in human GBM cells, in order to implement an innovative therapy to fight GBM cell resistance. With this purpose, RNAi technology was employed, and low serum-containing medium was used to mimic nutrient deficiency conditions, at which SCD1 is overexpressed. Besides the expected increase in the saturated to unsaturated fatty acid ratio in SCD1 silenced-GBM cells, a striking increase in polyunsaturated chains, particularly in phosphatidylethanolamine and cardiolipin species, was noticed and tentatively correlated with an increase in autophagy (evidenced by the increase in LC3BII/I ratio). The contribution of autophagy to mitigate the impact of SCD1 silencing on GBM cell viability and growth, whose modest inhibition could be correlated with the maintenance of energetically associated mitochondria, was evidenced by using autophagy inhibitors. In conclusion, SCD1 silencing could constitute an important tool to halt GBM resistance to the available treatments, especially when coupled with a mitochondria disrupter chemotherapeutic.

18 December 2024 in Journal of Chromatography A
Verified
Journal Article
Open access
AAAna Rita Dias Araújo
Ana Rita Dias Araújo
OBOcéane Buvry
Océane Buvry
BABruno Antonny
Bruno Antonny
DDDelphine Debayle
Delphine Debayle
The introduction of high-performance TLC (HPTLC) instrumentation that allows precise control of critical parameters has transformed the technique into an efficient and rapid tool for analyzing various metabolites, namely lipids. Although mass spectrometry (MS) has largely replaced lipid analysis techniques over recent decades due to its comprehensive lipidome profiling capabilities, it typically lacks the rapidity and simplicity of TLC. HPTLC remains advantageous due to its ease of use, simpler data interpretation, and compatibility with complementary techniques. In this study, we established a HPTLC protocol to fractionate both polar and non-polar lipids on a single normal phase plate. Twenty lipid standards were fractionated and the method was successfully applied to whole extracts from six mammalian cell lines. Standards and extracted lipids were applied with an automated sampler, and polar lipids were first fractionated in a 5-step automated gradient elution, followed by the fractionation of neutral lipids in a twin-trough chamber with three different elutions. Plates were automatically sprayed with a modified copper sulfate solution and charred to reveal lipids and obtain the respective chromatograms. LC-MS was used to identify ambiguous bands, thus ensuring the accuracy of lipid identification.

26 December 2025 in Journal of Cell Biology
Verified
Journal Article
Closed access
HSHeitor Gobbi Sebinelli
Heitor Gobbi Sebinelli
CSCamille Syska
Camille Syska
HRHafez Razmazma
Hafez Razmazma
VAVéronique Albanèse
Véronique Albanèse
AAAna Rita Dias Araujo
Ana Rita Dias Araujo
AČAlenka Čopič
Alenka Čopič
Lipid scramblases allow passive flip-flop of phospholipids between bilayer leaflets, thereby promoting membrane symmetry. At the endoplasmic reticulum (ER), where phospholipid synthesis is restricted to one leaflet, scramblase activity should be essential for equilibrated membrane growth. The yeast protein Ist2 contains an ER domain and a cytosolic tail that binds the plasma membrane and participates in the transfer of phosphatidylserine. We show both in vitro and in silico that the ER domain of Ist2, which bears homology to the TMEM16 proteins, possesses a lipid scramblase activity that is not regulated by Ca2+. In cells, overexpression or deletion of the ER domain of Ist2 affects ER-related processes including COPII-mediated vesicular transport, lipid droplet homeostasis, and general phospholipid transport, with a specific contribution of residues implicated in lipid scrambling. The weak phenotypes can be augmented by the deletion of another putative scramblase, the protein insertase Get1, suggesting that the combined action of different proteins supports lipid scrambling at the ER.

10 December 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
DKDavid Kovacs
David Kovacs
AGAnne-Sophie Gay
Anne-Sophie Gay
LFLucile Fleuriot
Lucile Fleuriot
DDDelphine Debayle
Delphine Debayle
AAAna Rita Dias Araújo
Ana Rita Dias Araújo
BABruno Antonny
Bruno Antonny
Golgi lipid environment regulates sorting and cargo secretion. However, the mechanisms that spatiotemporally control the lipid composition of the secretory membranes to drive cargo trafficking are poorly understood. Lipid transfer proteins regulate the concentration of specific lipids at membrane contact sites. We hypothesised that by catalysing cholesterol/PI(4)P exchange at ER- trans -Golgi membrane contact sites the lipid transfer protein oxysterol binding protein (OSBP) affects the secretion of a subset of cargoes. Here, we report that OSBP is a major epithelial protein as its inhibition leads to complete loss of apico-basal polarity. By mapping the OSBP proximity proteome with the biotin ligase TurboID, we found that OSBP controls the secretion of multiple membrane associated proteins, including key polarity determinants such as E-cadherin. Mechanistically, we established that OSBP contributes to E-cadherin secretion by supplying cholesterol to post-Golgi membranes. Importantly, when cells downregulate cell-cell junctions upon epithelial-to-mesenchymal transition, they re-wire their lipid homeostasis and downregulate OSBP as well, thus altering the trafficking of the OSBP-dependent secretory cargoes.

3 September 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
SFScott Frendo-Cumbo
Scott Frendo-Cumbo
DZDanae Stella Zareifi
Danae Stella Zareifi
JBJoëlle Bigay
Joëlle Bigay
AAAna Rita Dias Araújo
Ana Rita Dias Araújo
ALAlina Lapp
Alina Lapp
NMNiklas Mejhert
Niklas Mejhert
Insulin-driven gene regulation is central to adipocyte function, but the roles of many of these genes in lipid metabolism remain unclear. Here, we integrate three transcriptomic datasets to identify insulin-responsive genes and define their functions in human adipocytes using a multiparametric lipid turnover screen. Our results reveal four major clusters involved in metabolic regulation, transcription, stress responses, and lipid metabolism. Among lipid-related hits, phospholipase C X domain-containing protein-1 (PLCXD1) emerges as a regulator of insulin-stimulated lipogenesis, without affecting lipolysis or adipogenesis. PLCXD1 is induced by insulin via sterol regulatory element-binding proteins, a response attenuated in insulin-resistant states. This atypical phospholipase is genetically associated with fat mass-related traits, localizes to early endosomes and catalyzes phosphatidylinositol conversion into diacylglycerol. Through structure-function analyses, we show that PLCXD1 catalytic activity is required for insulin-stimulated lipogenesis. Altogether, our results uncover PLCXD1 as an insulin-regulated enzyme linking endosomal phosphoinositide metabolism to lipid storage in adipocytes.